You are here

  • Home
  • Archive
  • Volume 83, Issue Suppl 1
  • AB0569 PATIENT-REPORTED OUTCOMES (PROs), DISEASE ACTIVITY AND SAFETY IN 1,177 PATIENTS WITH RHEUMATOID ARTHRITIS (RA) TREATED WITH FILGOTINIB FOR UP TO 18 MONTHS: INTERIM RESULTS FROM FILOSOPHY AND PARROTFISH

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Publication Only
Rheumatoid arthritis
AB0569 PATIENT-REPORTED OUTCOMES (PROs), DISEASE ACTIVITY AND SAFETY IN 1,177 PATIENTS WITH RHEUMATOID ARTHRITIS (RA) TREATED WITH FILGOTINIB FOR UP TO 18 MONTHS: INTERIM RESULTS FROM FILOSOPHY AND PARROTFISH

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Avouac J, Burmester GR, Caporali RF, et al
AB0569 PATIENT-REPORTED OUTCOMES (PROs), DISEASE ACTIVITY AND SAFETY IN 1,177 PATIENTS WITH RHEUMATOID ARTHRITIS (RA) TREATED WITH FILGOTINIB FOR UP TO 18 MONTHS: INTERIM RESULTS FROM FILOSOPHY AND PARROTFISH
Annals of the Rheumatic Diseases 2024;83:1565-1566.